These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10406220)

  • 1. Structural recognition of an ICAM-1 peptide by its receptor on the surface of T cells: conformational studies of cyclo (1, 12)-Pen-Pro-Arg-Gly-Gly-Ser-Val-Leu-Val-Thr-Gly-Cys-OH.
    Gürsoy RN; Jois DS; Siahaan TJ
    J Pept Res; 1999 Apr; 53(4):422-31. PubMed ID: 10406220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and internalization of an ICAM-1 peptide by the surface receptors of T cells.
    Gürsoy RN; Siahaan TJ
    J Pept Res; 1999 Apr; 53(4):414-21. PubMed ID: 10406219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of a novel T-cell adhesion inhibitor derived from the fragment of ICAM-1 receptor: cyclo(1,8)-Cys-Pro-Arg-Gly-Gly-Ser-Val-Cys.
    Tejo BA; Siahaan TJ
    Biopolymers; 2009 Aug; 91(8):633-41. PubMed ID: 19330816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and ICAM-1-docking properties of a cyclic peptide from the I-domain of LFA-1: an inhibitor of ICAM-1/LFA- 1-mediated T-cell adhesion.
    Xu CR; Yusuf-Makagiansar H; Hu Y; Jois SD; Siahaan TJ
    J Biomol Struct Dyn; 2002 Apr; 19(5):789-99. PubMed ID: 11922836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of homotypic adhesion of T-cells: secondary structure of an ICAM-1-derived cyclic peptide.
    Jois DS; Pal D; Tibbetts SA; Chan MA; Benedict SH; Siahaan TJ
    J Pept Res; 1997 Jun; 49(6):517-26. PubMed ID: 9266479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Ca2+ binding cyclic peptide derived from the alpha-subunit of LFA-1: inhibitor of ICAM-1/LFA-1-mediated T-cell adhesion.
    Jois SD; Tibbetts SA; Chan MA; Benedict SH; Siahaan TJ
    J Pept Res; 1999 Jan; 53(1):18-29. PubMed ID: 10195438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of binding and internalization of ICAM-1-derived cyclic peptides by LFA-1 on the surface of T cells: a potential method for targeted drug delivery.
    Anderson ME; Siahaan TJ
    Pharm Res; 2003 Oct; 20(10):1523-32. PubMed ID: 14620502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of a peptide derived from the beta subunit of LFA-1.
    Shuxing Z; Ying WS; Siahaan TJ; Jois SD
    Peptides; 2003 Jun; 24(6):827-35. PubMed ID: 12948834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide derived from LFA-1 protein that modulates T-cell adhesion binds to soluble ICAM-1 protein.
    Jois SD; Teruna TJ
    J Biomol Struct Dyn; 2003 Apr; 20(5):635-44. PubMed ID: 12643766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural modifications of ICAM-1 cyclic peptides to improve the activity to inhibit heterotypic adhesion of T cells.
    Iskandarsyah ; Tejo BA; Tambunan US; Verkhivker G; Siahaan TJ
    Chem Biol Drug Des; 2008 Jul; 72(1):27-33. PubMed ID: 18554252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of conformation on the conversion of cyclo-(1,7)-Gly-Arg-Gly-Asp-Ser-Pro-Asp-Gly-OH to its cyclic imide degradation product.
    Bogdanowich-Knipp SJ; Jois SD; Siahaan TJ
    J Pept Res; 1999 Jul; 54(1):43-53. PubMed ID: 10448969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1).
    McDowall A; Leitinger B; Stanley P; Bates PA; Randi AM; Hogg N
    J Biol Chem; 1998 Oct; 273(42):27396-403. PubMed ID: 9765268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution conformations of two flexible cyclic pentapeptides: cyclo(Gly-Pro-D-Phe-Gly-Ala) and cyclo(Gly-Pro-D-Phe-Gly-Val).
    Stroup AN; Rockwell AL; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1713-25. PubMed ID: 1472654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution.
    Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS
    J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
    Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
    Liu ZP; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of binding properties of ICAM-1 peptides to LFA-1: inhibitors of T-cell adhesion.
    Anderson ME; Tejo BA; Yakovleva T; Siahaan TJ
    Chem Biol Drug Des; 2006 Jul; 68(1):20-8. PubMed ID: 16923022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a micellar environment on the conformations of two cyclic pentapeptides.
    Bruch MD; Rizo J; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1741-54. PubMed ID: 1472656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CD and an NMR study of multiple bradykinin conformations in aqueous trifluoroethanol solutions.
    Cann JR; Liu X; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1994 Jul; 34(7):869-78. PubMed ID: 8054469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational study of cyclo[D-Trp-D-Asp-Pro-D-Val-Leu], an endothelin-A receptor-selective antagonist.
    Atkinson RA; Pelton JT
    FEBS Lett; 1992 Jan; 296(1):1-6. PubMed ID: 1309703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.